AntriaBio, Inc. — Form D
AntriaBio, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-11. The offering totals $1.0M, of which $825K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-01-11
- Form: D
- Accession: 0001140361-13-001819
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $825K
- Remaining: $175K
- Investors: 8
- Date of first sale: 2012-12-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-190019
Issuer
- Name: AntriaBio, Inc.
- CIK: 0001556406
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 999 18TH STREET, SUITE 3000, DENVER, CO, 80202
- Phone: 303-357-4644
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Steve R Howe | Director | Denver, CO |
| Nickolav R Kukekov | Director | Denver, CO |
| Steve R Howe | Executive Officer | Denver, CO |
| Nickolav R. Kukekov | Director | Denver, CO |
| Steve R. Howe | Director | Denver, CO |
| Steve R. Howe | Executive Officer | Denver, CO |
Other filings by this issuer (1)
More